Grand Rounds May 19, 2023: Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis After a Fracture (Robert O’Toole, MD)
Rethinking Clinical Trials
MAY 25, 2023
Prophylaxis (chemical or mechanical) reduces risk deep vein thrombosis (DVT) by around 50%. Tags #pctGR, @Collaboratory1 The post Grand Rounds May 19, 2023: Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis After a Fracture (Robert O’Toole, MD) appeared first on Rethinking Clinical Trials.
Let's personalize your content